Literature DB >> 202665

Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.

T Sairenji, Y Hinuma, T Sekizawa, M Yoshida.   

Abstract

This study investigated the synthesis of membrane antigen (MA) as well as virus capsid antigen (VCA) and early antigen (EA) in Daudi cells which had been superinfected with the P3HR-1 strain of Epstein-Barr virus (EBV) and then treated with trypsin to remove initially absorbed MA-positive material from the cell surface. Synthesis of MA, VCA and EA was completely inhibited by puromycin. A marked reduction in the frequency of MA positive cells was observed in superinfected cells cultured in the presence of either cytosine arabinoside (Ara-C) or phosphonoacetate (PA); however, a small fraction of MA synthesis occurred, suggesting an inhibitor insensitive component in MA, A differential absorption of EBV antibody-positive human serum with the Ara-C treated or untreated infected cells detected two antigenically different components in MA: early (Ara-C insensitive) and late (Ara-C sensitive) MA.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 202665     DOI: 10.1099/0022-1317-38-1-111

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Detection by monoclonal antibodies of an early membrane protein induced by Epstein-Barr virus.

Authors:  N Balachandran; J Pittari; L M Hutt-Fletcher
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

2.  Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.

Authors:  T Sairenji; G Bertoni; M M Medveczky; P G Medveczky; Q V Nguyen; R E Humphreys
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

3.  Herpesvirus-induced "early" glycoprotein: characterization and possible role in immune cytolysis.

Authors:  V Misra; J E Gilchrist; G Weinmaster; L Qualtiere; S Van den Hurk; L A Babiuk
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

4.  Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.

Authors:  S F Slovin; D M Frisman; C D Tsoukas; I Royston; S M Baird; S B Wormsley; D A Carson; J H Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

5.  Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.

Authors:  T Sairenji; P S Reisert; R C Spiro; T Connolly; R E Humphreys
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.